TAYLOR BELAIRE: Open Payments
NPI 1730773524 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 60 payments from 18 companies in 2025. Trend: 2023 $1,458 · 2024 $1,265 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $187 |
| Novo Nordisk Inc | 14 | $180 |
| Dexcom, Inc. | 5 | $95 |
| Abbott Laboratories | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Lilly USA, LLC | 3 | $54 |
| Kestra Medical Technology Services, Inc. | 1 | $47 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $40 |
Products named: Ozempic, Dexcom G6 Transmitter, VRAYLAR, FREESTYLE LIBRE 3, Kerendia, QULIPTA, MOUNJARO, Assure WCD.
Industry payments across LA — which companies pay providers there.
